SunCoke Energy (SXC) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
17 Feb, 2026Executive summary
Achieved a Total Recordable Incident Rate (TRIR) of 0.55 in 2025, reflecting strong safety performance.
Completed the acquisition and integration of Phoenix Global, expanding the Industrial Services segment and contributing to segment growth.
Extended key coke-making contracts at Granite City (through 2026) and Haverhill II (through 2028).
Maintained a quarterly dividend of $0.12/share, totaling $0.48/share and $41 million returned to shareholders in 2025.
Reported a net loss of $44.2 million for 2025, impacted by significant one-time items including asset impairments and restructuring costs.
Financial highlights
FY 2025 Adjusted EBITDA was $219.2 million, down $53.6 million year-over-year, mainly due to lower coke sales, contract mix changes, and the Algoma breach.
Fourth quarter 2025 net loss was $1 per share, impacted by $0.85 per share in one-time items.
Full year 2025 net loss was $0.52 per share, down $1.64 year-over-year, mainly due to one-time items and contract mix changes.
Operating cash flow for 2025 was $109.1 million; capital expenditures totaled $66.8 million.
Ended 2025 with $88.7 million in cash and $221 million in liquidity.
Outlook and guidance
2026 consolidated adjusted EBITDA expected between $230 million and $250 million, driven by a full year of Phoenix Global and improved terminal volumes.
Domestic coke adjusted EBITDA projected at $162–$168 million with 3.4 million tons in sales.
Industrial services adjusted EBITDA expected at $90–$100 million, supported by Phoenix Global and improved market conditions.
CapEx for 2026 anticipated at $90–$100 million; free cash flow expected between $140 million and $150 million.
Net income for 2026 projected between $25 million and $43 million; deleveraging prioritized with gross leverage targeted at 2.45x by year-end.
Latest events from SunCoke Energy
- Q3 adjusted EBITDA hit $75.3M, net income rose, and 2024 guidance was raised on regulatory gain.SXC
Q3 202413 Feb 2026 - Q2 Adjusted EBITDA hit $63.5M, with a 20% dividend hike and strong full-year outlook.SXC
Q2 20242 Feb 2026 - 2024 Adjusted EBITDA exceeded guidance; 2025 faces margin pressure but strong liquidity persists.SXC
Q4 20249 Jan 2026 - 2025 meeting to vote on directors, pay, and auditor amid strong results and robust governance.SXC
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor on May 15, 2025.SXC
Proxy Filing1 Dec 2025 - Q1 2025 profit fell on weak coke sales, but guidance and liquidity remain strong.SXC
Q1 202528 Nov 2025 - $325M acquisition expands reach, diversifies earnings, and delivers immediate accretion and synergies.SXC
M&A Announcement25 Nov 2025 - Q2 2025 earnings fell, but liquidity is strong and a $325M acquisition closes August 1.SXC
Q2 202516 Nov 2025 - Q3 2025 Adjusted EBITDA dropped to $59.1M, with FY guidance cut to $220–$225M after a contract breach.SXC
Q3 202513 Nov 2025